Fund Iv L.P. Omega's Net Worth

Fund Iv L.P. Omega's net worth is estimated to be at least $14,182,082.02 as of 11/23/2024. CoreStreet's estimation of Fund Iv L.P. Omega's net worth is based on their sale of stock and current holding of stock.

Fund Iv L.P. Omega is Major Shareholder at Replimune Group Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 16,500 units of REPL stock on 03/14/2022. Their biggest sale was on 01/26/2021 when they sold 30,350 units of Replimune Group Inc stock for $1,378,497.00. They typically trade 3 times per year.

Total value of insider buys:
  • $8,994,194.00
Total value of insider sells:
  • $5,187,888.02
Most recent insider trade:
  • March 14, 2022

Fund Iv L.P. Omega's Insider Trading History

Replimune Group IncTitleAmountPriceTypeTotal Value
March 14, 2022
Major Shareholder16,500$15.42Sell$254,430.00
Nov. 22, 2021
Director10,162$34.70Sell$352,621.40
Nov. 18, 2021
Director2,441$33.50Sell$81,773.50
Nov. 15, 2021
Director782$33.66Sell$26,322.12
Nov. 12, 2021
Director23,235$33.66Sell$782,090.10
Nov. 10, 2021
Director11$33.50Sell$368.50
Nov. 8, 2021
Director3,817$33.53Sell$127,984.01
Nov. 4, 2021
Director25,225$33.58Sell$847,055.50
Sept. 23, 2021
Director12,171$33.58Sell$408,702.18
Sept. 16, 2021
Director5,537$32.55Sell$180,229.35
Feb. 8, 2021
Major Shareholder5,249$45.00Sell$236,205.00
Jan. 26, 2021
Director30,350$45.42Sell$1,378,497.00
Jan. 22, 2021
Director11,359$45.04Sell$511,609.36
Nov. 18, 2019
Major Shareholder220,000$13.61Buy$2,994,200.00
Paratek Pharmaceuticals IncTitleAmountPriceTypeTotal Value
June 27, 2016
Major Shareholder461,538$13.00Buy$5,999,994.00